质母细胞瘤表观遗传学揭示了复杂的生物学和潜在的治疗点
Zoltán Krabóth1, Márton Tompa2, Péter Urbán2
1Department of Pathology, School of Medicine, Clinical Center, University of Pécs, Pécs.
概括
这项研究分析了质母细胞瘤 (GBM) 的表观遗传学,以揭示早期和晚期瘤决定因素. 研究结果揭示了免疫,神经递质和干细胞通路的改变,为这种侵略性脑癌提供了潜在的治疗见解.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有复杂分子基础的侵袭性脑瘤.
- 虽然OMICS数据已经为诊断提供了信息,但临床整合仍然有限.
- 了解GBM的早期和晚期发育对于改善疗法至关重要.
研究的目的:
- 为了展示质母细胞瘤的表观基因组分析结果.
- 阐明GBM的早期和晚期分子决定因素.
- 与执业的临床医生分享关键发现.
主要方法:
- 从24个顺序的GBM组织对 (GBM1和GBM2) 中分析了DNA.
- 利用减少表示的二硫酸盐序列为图书馆准备.
- 进行生物信息分析以确定差异甲基化途径.
主要成果:
- 鉴定了GBM与对照中的不同甲基化途径,包括发育过程.
- 在复发性GBM中观察到免疫调节,神经递质通路 (多巴胺基,诺阿德仁基,谷氨酸基) 和干细胞调节的显著变化.
- 突出了原发性和复发性瘤之间的明显分子变化.
结论:
- 质母细胞瘤的发展涉及复杂的细胞内,神经发育,免疫和神经递质通路的改变.
- 这些发现提供了关于质生成机制的见解.
- 这些结果可能会为未来的质母细胞瘤治疗策略提供信息.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


